SEC Form 4
Sight Sciences, Inc. (SGHT) insider trading
In the 12 months to Oct 26, 2026, 6 SGHT insiders reported open-market sales of $2.9M across 32 filings; one director bought $184.8K.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $2.9M
- 32 filings · 6 insiders
- Open-market purchases
- $184.8K
- 2 filings · Staffan Encrantz, Director
- Pre-arranged sales (10b5-1)
- 25 of 32
- $2.2M of $2.9M sold (76%)
Who traded SGHT, and when
- Purchase
- Sale
- Sale, pre-arranged (10b5-1)
SGHT daily close from Oct 27, 2025 to Oct 26, 2026, between $3.45 and $9.36, last $9.06. 32 sale and 2 purchase filings by 7 insiders, marked at their filing dates. Paul Badawi, President and CEO: sold $957.2K across 5 filings, first filed Jan 6, 2026, last Oct 5, 2026. Alison Bauerlein, Chief Operating Officer: sold $665.8K across 5 filings, first filed Jan 6, 2026, last Oct 5, 2026. Jeremy B. Hayden, Chief Legal Officer: sold $635.1K across 6 filings, first filed Nov 14, 2025, last Jul 6, 2026. David Badawi, Chief Technology Officer: sold $245.0K across 5 filings, first filed Jan 6, 2026, last Oct 5, 2026. James Rodberg, Chief Financial Officer: sold $203.5K across 6 filings, first filed Dec 3, 2025, last Oct 5, 2026. Staffan Encrantz, Director: bought $184.8K across 2 filings, first filed Dec 18, 2025, last Jun 11, 2026. Brenton Taylor, EVP, Operations & R&D: sold $158.8K across 5 filings, first filed Nov 18, 2025, last Oct 5, 2026.
Largest mark · tap a row for others
Jeremy B. Hayden · Chief Legal Officer
Sale $362,388
44,850 shares at $8.08 avg
Filed Nov 26, 2025 · traded Nov 25
Pre-arranged (10b5-1) · close on filing date $8.39
Paul Badawi · President and CEO
President and CEO
$957.2K soldAlison Bauerlein · Chief Operating Officer
Chief Operating Officer
$665.8K soldJeremy B. Hayden · Chief Legal Officer
Chief Legal Officer
$635.1K soldDavid Badawi · Chief Technology Officer
Chief Technology Officer
$245.0K soldJames Rodberg · Chief Financial Officer
Chief Financial Officer
$203.5K soldStaffan Encrantz · Director
Director
$184.8K boughtBrenton Taylor · EVP, Operations & R&D
EVP, Operations & R&D
$158.8K soldOpen-market trades
34 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Paul Badawi | President and CEO | $957.2K | — | 5 | 71% of sales | |
| Alison Bauerlein | Chief Operating Officer | $665.8K | — | 5 | 76% of sales | |
| Jeremy B. Hayden | Chief Legal Officer | $635.1K | — | 6 | 100% of sales | |
| David Badawi | Chief Technology Officer | $245.0K | — | 5 | 70% of sales | |
| James Rodberg | Chief Financial Officer | $203.5K | — | 6 | 71% of sales | |
| Staffan Encrantz | Director | — | $184.8K | 2 | — | |
| Brenton Taylor | EVP, Operations & R&D | $158.8K | — | 5 | 33% of sales |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Paul Badawi President and CEO | SalePre-arranged (10b5-1) | 29,653 | $9.05 | $268.3K | 6,092,819 | |
traded | David Badawi Chief Technology Officer | SalePre-arranged (10b5-1) | 7,797 | $9.05 | $70.6K | 1,975,075 | |
traded | James Rodberg Chief Financial Officer | SalePre-arranged (10b5-1) | 7,208 | $8.85 | $63.8K | 216,829 | |
traded | Alison Bauerlein Chief Operating Officer | SalePre-arranged (10b5-1) | 25,260 | $8.85 | $223.6K | 639,449 | |
traded | Brenton Taylor EVP, Operations & R&D | SalePre-arranged (10b5-1) | 2,988 | $8.85 | $26.5K | 261,990 | |
traded | Paul Badawi President and CEO | SalePre-arranged (10b5-1) | 28,684 | $5.42 | $155.5K | 6,122,472 | |
traded | Alison Bauerlein Chief Operating Officer | SalePre-arranged (10b5-1) | 24,184 | $5.36 | $129.6K | 664,709 | |
traded | Brenton Taylor EVP, Operations & R&D | SalePre-arranged (10b5-1) | 2,829 | $5.42 | $15.3K | 264,978 | |
traded | David Badawi Chief Technology Officer | SalePre-arranged (10b5-1) | 7,418 | $5.51 | $40.9K | 1,982,872 | |
traded | James Rodberg Chief Financial Officer | SalePre-arranged (10b5-1) | 6,902 | $5.36 | $37.0K | 224,037 | |
traded | Jeremy B. Hayden Chief Legal Officer | SalePre-arranged (10b5-1) | 12,733 | $5.51 | $70.1K | 357,037 | |
traded | Staffan Encrantz Director | Purchase | 14,100 | $4.88 | $68.8K | 1,434,283 | |
traded | Alison Bauerlein Chief Operating Officer | SalePre-arranged (10b5-1) | 12,728 | $5.12 | $65.2K | 688,893 | |
traded | Jeremy B. Hayden Chief Legal Officer | SalePre-arranged (10b5-1) | 13,761 | $3.55 | $48.9K | 369,770 | |
traded | James Rodberg Chief Financial Officer | SalePre-arranged (10b5-1) | 7,231 | $3.55 | $25.7K | 230,939 | |
traded | Paul Badawi President and CEO | SalePre-arranged (10b5-1) | 29,244 | $3.70 | $108.2K | 6,151,156 | |
traded | Brenton Taylor EVP, Operations & R&D | SalePre-arranged (10b5-1) | 2,869 | $3.70 | $10.6K | 267,807 | |
traded | David Badawi Chief Technology Officer | SalePre-arranged (10b5-1) | 8,168 | $3.48 | $28.4K | 1,990,290 | |
traded | Alison Bauerlein Chief Operating Officer | SalePre-arranged (10b5-1) | 25,874 | $3.48 | $90.0K | 701,621 | |
traded | Jeremy B. Hayden Chief Legal Officer | SalePre-arranged (10b5-1) | 6,308 | $6.62 | $41.8K | 267,611 | |
traded | Paul Badawi President and CEO | SalePre-arranged (10b5-1) | 22,362 | $6.62 | $148.0K | 6,025,840 | |
traded | James Rodberg Chief Financial Officer | SalePre-arranged (10b5-1) | 2,616 | $6.62 | $17.3K | 151,230 | |
traded | David Badawi Chief Technology Officer | SalePre-arranged (10b5-1) | 4,836 | $6.62 | $32.0K | 1,912,273 | |
traded | Brenton Taylor EVP, Operations & R&D | Sale | 619 | $7.48 | $4.6K | 170,212 | |
traded | Alison Bauerlein Chief Operating Officer | Sale | 20,543 | $7.66 | $157.4K | 599,983 | |
traded | James Rodberg Chief Financial Officer | Sale | 4,999 | $7.78 | $38.9K | 153,846 | |
traded | David Badawi Chief Technology Officer | Sale | 9,660 | $7.57 | $73.1K | 1,917,109 | |
traded | Jeremy B. Hayden Chief Legal Officer | SalePre-arranged (10b5-1) | 11,170 | $7.77 | $86.7K | 245,420 | |
traded | Paul Badawi President and CEO | Sale | 37,226 | $7.45 | $277.2K | 5,925,276 | |
traded | Staffan Encrantz Director | Purchase | 13,958 | $8.31 | $116.0K | 1,391,922 | |
traded | James Rodberg Chief Financial Officer | Sale | 2,518 | $8.25 | $20.8K | 158,845 | |
traded | Jeremy B. Hayden Chief Legal Officer | SalePre-arranged (10b5-1) | 44,850 | $8.08 | $362.4K | 256,590 | |
traded | Brenton Taylor EVP, Operations & R&D | Sale | 14,418 | $7.06 | $101.8K | 170,831 | |
traded | Jeremy B. Hayden Chief Legal Officer | SalePre-arranged (10b5-1) | 3,150 | $8.01 | $25.2K | 256,590 |
GET /stocks/filings/vX/form-4?tickers=SGHT&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"SGHT"
],
"issuer_cik": "0001531177",
"owner_cik": "0001870865",
"accession_number": "0001193125-26-414272",
"form_type": "4",
"filing_date": "2026-10-05",
"period_of_report": "2026-10-01",
"issuer_name": "Sight Sciences, Inc.",
"issuer_trading_symbol": "SGHT",
"owner_name": "Badawi Paul",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": true,
"is_other": false,
"officer_title": "President and CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-01",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 29653,
"transaction_price_per_share": 9.049,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 6092819,
"transaction_value": 268329.997,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Reflects shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units (\"RSUs\")."
},
{
"id": "F2",
"description": "Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.87 to $9.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
},
{
"id": "F3",
"description": "Includes (i) 5,599,542 shares of Common Stock, and (ii) 493,277 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested."
}
]
},
{
"tickers": [
"SGHT"
],
"issuer_cik": "0001531177",
"owner_cik": "0001596103",
"accession_number": "0001193125-26-414283",
"form_type": "4",
"filing_date": "2026-10-05",
"period_of_report": "2026-10-02",
"issuer_name": "Sight Sciences, Inc.",
"issuer_trading_symbol": "SGHT",
"owner_name": "Taylor Brenton",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP, Operations & R&D",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-02",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 2988,
"transaction_price_per_share": 8.853,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 261990,
"transaction_value": 26452.764,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Reflects shares of the Issuer's common stock, par value $0.001 per share (\"Common Stock\"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units (\"RSUs\")."
},
{
"id": "F2",
"description": "Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.68 to $9.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
},
{
"id": "F3",
"description": "Includes (i) 41,602 shares of Common Stock, and (ii) 220,388 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 20 records
- Option exercises6 records
- Grants and awards14 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Sight Sciences, Inc.'s CEO sold stock?
Yes. Paul Badawi (CEO) sold 147,169 shares ($957.2K) between Jan 2026 and Oct 2026, $680.0K of it under a pre-arranged 10b5-1 plan.
How current is SGHT’s insider data?
These are SGHT Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track SGHT insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for SGHT every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.